Home NDC 27437-051 SOLOSEC
Product NDC 27437-051
11-digit product format 274370051
Labeler code 27437
Product ID 27437-051_fe8dadfb-2b46-433c-b3fa-9d9c3d0548b5
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name secnidazole
Dosage form GRANULE
Route ORAL
Labeler Lupin Pharmaceuticals, Inc.
Application NDA209363
Marketing category NDA
Marketing start 2017-10-30
Marketing end 0000-00-00
Substance SECNIDAZOLE
Active strength 2 g/4.8g
Pharmacologic classes Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 6 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 27437-051-02 d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 27437-051-01 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 27437-051-02 f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 27437-051-01 f5e01cc5f278…a2eaf40c39c3…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N209363-001 SOLOSEC SECNIDAZOLE 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15
Orange Book patents# Current patent rows page 1 of 1 · 33 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N209363-001 10335390 2035-09-04 U-2583 Drug product 2019-07-31 N209363-001 10335390 2035-09-04 U-3270 Drug product 2019-07-31 N209363-001 10682338 2035-09-04 U-2583 Drug product 2020-06-23 N209363-001 10682338 2035-09-04 U-3270 Drug product 2020-06-23 N209363-001 10849884 2035-09-04 U-2583 Drug product 2020-12-11 N209363-001 10849884 2035-09-04 U-3169 Drug product 2020-12-11 N209363-001 10849884 2035-09-04 U-3270 Drug product 2020-12-11 N209363-001 10849884 2035-09-04 U-3302 Drug product 2020-12-11 N209363-001 10857133 2035-09-04 U-2583 Drug product 2020-12-11 N209363-001 10857133 2035-09-04 U-3270 Drug product 2020-12-11 N209363-001 11000507 2035-09-04 U-2583 Drug product 2021-06-07 N209363-001 11000507 2035-09-04 U-3169 Drug product 2021-06-07 N209363-001 11000507 2035-09-04 U-3270 Drug product 2021-06-07 N209363-001 11000507 2035-09-04 U-3302 Drug product 2021-06-07 N209363-001 11000508 2035-09-04 U-2583 Drug product 2021-06-07 N209363-001 11000508 2035-09-04 U-3169 Drug product 2021-06-07 N209363-001 11000508 2035-09-04 U-3270 Drug product 2021-06-07 N209363-001 11000508 2035-09-04 U-3302 Drug product 2021-06-07 N209363-001 11020377 2035-09-04 U-2583 Drug product 2021-06-16 N209363-001 11020377 2035-09-04 U-3169 Drug product 2021-06-16 N209363-001 11020377 2035-09-04 U-3270 Drug product 2021-06-16 N209363-001 11020377 2035-09-04 U-3302 Drug product 2021-06-16 N209363-001 11324721 2035-09-04 U-2583 Drug product 2022-05-18 N209363-001 11324721 2035-09-04 U-3169 Drug product 2022-05-18 N209363-001 11324721 2035-09-04 U-3270 Drug product 2022-05-18 N209363-001 11324721 2035-09-04 U-3302 Drug product 2022-05-18 N209363-001 11602522 2035-09-04 U-3169 Drug product 2023-03-27 N209363-001 11602522 2035-09-04 U-3302 Drug product 2023-03-27 N209363-001 11684607 2035-09-16 U-2583 Drug product 2023-07-07 N209363-001 11684607 2035-09-16 U-3169 Drug product 2023-07-07 N209363-001 11684607 2035-09-16 U-3270 Drug product 2023-07-07 N209363-001 11684607 2035-09-16 U-3302 Drug product 2023-07-07 N209363-001 12280037 2041-12-11 U-3302 2025-05-19
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N209363-001 NCE 2022-09-15 N209363-001 GAIN 2027-09-15
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N209363-001 SOLOSEC 2GM/PACKET GRANULE / ORAL RLD, RS 2017-09-15 e64feba35796…
Observed Orange Book patent history# Patent history page 1 of 26 · 1,002 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N209363-001 10335390 2035-09-04 U-2583 Drug product 2019-07-31 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 10335390 2035-09-04 U-3270 Drug product 2019-07-31 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 10682338 2035-09-04 U-3270 Drug product 2020-06-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 10682338 2035-09-04 U-2583 Drug product 2020-06-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 10849884 2035-09-04 U-3270 Drug product 2020-12-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 10849884 2035-09-04 U-3302 Drug product 2020-12-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 10849884 2035-09-04 U-3169 Drug product 2020-12-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 10849884 2035-09-04 U-2583 Drug product 2020-12-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 10857133 2035-09-04 U-3270 Drug product 2020-12-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 10857133 2035-09-04 U-2583 Drug product 2020-12-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 11000507 2035-09-04 U-3302 Drug product 2021-06-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 11000507 2035-09-04 U-3270 Drug product 2021-06-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 11000507 2035-09-04 U-3169 Drug product 2021-06-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 11000507 2035-09-04 U-2583 Drug product 2021-06-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 11000508 2035-09-04 U-3302 Drug product 2021-06-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 11000508 2035-09-04 U-3270 Drug product 2021-06-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 11000508 2035-09-04 U-3169 Drug product 2021-06-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 11000508 2035-09-04 U-2583 Drug product 2021-06-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 11020377 2035-09-04 U-3302 Drug product 2021-06-16 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 11020377 2035-09-04 U-3270 Drug product 2021-06-16 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 11020377 2035-09-04 U-3169 Drug product 2021-06-16 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 11020377 2035-09-04 U-2583 Drug product 2021-06-16 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 11324721 2035-09-04 U-2583 Drug product 2022-05-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 11324721 2035-09-04 U-3169 Drug product 2022-05-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 11324721 2035-09-04 U-3270 Drug product 2022-05-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 11324721 2035-09-04 U-3302 Drug product 2022-05-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 11602522 2035-09-04 U-3169 Drug product 2023-03-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 11602522 2035-09-04 U-3302 Drug product 2023-03-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 11684607 2035-09-16 U-2583 Drug product 2023-07-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 11684607 2035-09-16 U-3169 Drug product 2023-07-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 11684607 2035-09-16 U-3270 Drug product 2023-07-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 11684607 2035-09-16 U-3302 Drug product 2023-07-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209363-001 12280037 2041-12-11 U-3302 2025-05-19 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209363-001 10335390 2035-09-04 U-2583 Drug product 2019-07-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209363-001 10335390 2035-09-04 U-3270 Drug product 2019-07-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209363-001 10682338 2035-09-04 U-3270 Drug product 2020-06-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209363-001 10682338 2035-09-04 U-2583 Drug product 2020-06-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209363-001 10849884 2035-09-04 U-3270 Drug product 2020-12-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209363-001 10849884 2035-09-04 U-3302 Drug product 2020-12-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209363-001 10849884 2035-09-04 U-3169 Drug product 2020-12-11 011fe1cb6892…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 4 · 140 observed states.
FDA-Initiated Inactive NDC Indexing# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 27437-051 SOLOSEC (SECNIDAZOLE) GRANULE [LUPIN PHARMACEUTICALS, INC.] 14 Legacy NDC 20220727_551e43d5-f700-4d6e-8029-026f8a8932ff.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 27437-051-01 27437005101 1 PACKET in 1 BOX, UNIT-DOSE (27437-051-01) > 2 g in 1 PACKET 1 packet 2017-10-30 0000-00-00 No No Current 27437-051-02 27437005102 1 PACKET in 1 BOX, UNIT-DOSE (27437-051-02) > 2 g in 1 PACKET 1 packet 2019-03-19 0000-00-00 No No Current 27437-051-05 27437005105 5 BOX, UNIT-DOSE in 1 CARTON (27437-051-05) > 1 PACKET in 1 BOX, UNIT-DOSE (27437-051-02) > 2 g in 1 PACKET 2019-03-19 0000-00-00 No No Current 27437-051-12 27437005112 12 BOX, UNIT-DOSE in 1 CARTON (27437-051-12) > 1 PACKET in 1 BOX, UNIT-DOSE (27437-051-01) > 2 g in 1 PACKET 2017-10-30 0000-00-00 No No Current